The court's decision on the takeover bid for Pixium Vision is expected on January 31, the bionic vision specialist announced on Thursday.

On December 18, the Paris Commercial Court was due to rule on the only takeover offer received to date by the receivers of this medtech company, which is in receivership.

On this occasion, the court will also have to rule on the follow-up to the receivership proceedings in which the inventor of the Prima wireless photovoltaic subretinal micro-implant finds itself.

The company plans to ask Euronext Paris to suspend the listing of its shares on January 31.

In the meantime, shares listed on the Paris Bourse climbed by over 40% on Thursday, bringing their gains over the last five trading sessions to almost 185%.

Copyright (c) 2024 CercleFinance.com. All rights reserved.